<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01824173</url>
  </required_header>
  <id_info>
    <org_study_id>12-004000</org_study_id>
    <nct_id>NCT01824173</nct_id>
  </id_info>
  <brief_title>Muscle Protein Metabolism in Obesity</brief_title>
  <official_title>Regulation of Muscle ATP Synthase Beta Subunit Metabolism in Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is associated with reduced adenosine triphosphate (ATP) turnover in skeletal muscle,
      a condition that can impair muscle metabolism. The proposed research will discover mechanisms
      responsible for decreased content in mitochondrial proteins as well as in protein
      β-F1-ATPase, which is directly responsible for ATP assembly, in the muscle of obese
      individuals. This research will further examine the effectiveness of interventions, such as
      increased plasma amino acid availability and exercise, to increase the rate of production of
      mitochondrial proteins as well as that of β-F1-ATPase in the muscle of obese individuals. The
      findings will help to develop appropriate interventions to improve muscle ATP turnover and
      metabolism in obese people.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 2012</start_date>
  <completion_date type="Anticipated">July 20, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 20, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of synthesis of muscle proteins (mixed muscle proteins, mitochondrial proteins, β-F1-ATPase)</measure>
    <time_frame>Measured during a 9-hour infusion study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>β-F1-ATPase mRNA expression; PGC-1 expression</measure>
    <time_frame>Measured during a 9-hour infusion study</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Amino Acid Infusion in Lean</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amino Acid Infusion in Lean</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amino acid Infusion in Obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amino acid Infusion in Obese</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise in lean</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise in lean</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise in Obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise in Obese</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Increase in the levels of plasma amino acids</intervention_name>
    <description>Aminosyn 15%; 160 mg/kg FFM/h for 4 hours</description>
    <arm_group_label>Amino Acid Infusion in Lean</arm_group_label>
    <arm_group_label>Amino acid Infusion in Obese</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic exercise</intervention_name>
    <description>Moderate intensity for 45 minutes</description>
    <arm_group_label>Exercise in lean</arm_group_label>
    <arm_group_label>Exercise in Obese</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Body mass index (BMI): lean, 19-26 kg/m2; obese, 30-40 kg/m2

          2. Availability of transportation

          3. Ability to sign informed consent form

        Exclusion criteria:

          1. Medication or supplements (i.e. amino acids, protein) known to affect protein
             metabolism

          2. Presence of acute illness

          3. History of liver disease

          4. Uncontrolled metabolic disease

          5. ECG documented abnormalities, atrial fibrillation, history of syncope, limiting or
             unstable angina, or congestive heart failure

          6. Chronically elevated blood pressure (systolic, &gt;140 mmHg; diastolic, &gt;100 mmHg)

          7. Cardiac pacemaker or other medical device implanted in the body

          8. Low hemoglobin or hematocrit

          9. Current participation in a weight-loss regimen, including extreme dietary practices

         10. Smoking

         11. Use of anabolic steroids or corticosteroids (within 3 months)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lori Roust, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christos S Katsanos, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona State University/Mayo Clinic Arizona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2013</study_first_submitted>
  <study_first_submitted_qc>April 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2013</study_first_posted>
  <last_update_submitted>November 22, 2017</last_update_submitted>
  <last_update_submitted_qc>November 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Lori R. Roust</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>muscle</keyword>
  <keyword>mitochondria</keyword>
  <keyword>amino acids</keyword>
  <keyword>exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

